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Abstract The generation of lipid second messengers via
phosphatidylcholine (PC)-specific phospholipase D (PLD) has
emerged as an important step leading to transduction of
extracellular signals. In the present investigation the expression
of human cytosolic PLD isoenzymes in the immortalized human
keratinocyte cell line HaCat was determined. At the mRNA level
we found the expression of hPLD1b and for the first time in
human cells also the expression of hPLD2. For further analysis
of enzyme expression at the protein level, hPLD1 peptide
fragments were synthesized and specific antibodies were
generated (rabbit) to be used for detection of hPLD1 in Western
blot experiments. Furthermore, small G-proteins were found to
be involved in the regulation of PLD activity in HaCaT cells
using the guanine nucleotide analogue GTPQS.
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1. Introduction
Lipid metabolism plays a crucial role in cell signalling. For
example, eikosanoids, diacylglycerol, ceramides, sphingosine-
1-phosphate, lysophosphatidic acid and platelet activating fac-
tor (PAF) induce and/or mediate cellular responses in many
cell types. Phosphatidylcholine-speci¢c phospholipase D
(PLD) is an enzyme that catalyzes the hydrolysis of phospha-
tidylcholine (PC) to produce phosphatidic acid and choline. A
great variety of stimuli increase PLD activity in a wide range
of cell types and the consequent increase of phosphatidic acid,
or a metabolite of this lipid, mediates PLD-induced cell sig-
nalling (for review see [1,2]). A considerable portion of the
protein kinase C activator diacylglycerol arises from PLD-
generated phosphatidic acid by the action of phosphatidate
phosphohydrolase [3]. Studies on the regulation of PLD sug-
gest that this enzyme may play a role in mitogenic signalling
processes controlled by monomeric G-proteins of the ADP-
ribosylation factor (ARF) and Rho families, and in intracel-
lular vesicle tra⁄cking [4,5]. Cloning of PLD isoenzymes from
plants [6] as well as from yeast [7] and humans [8] provides
new insights into the regulation and the structure-function
relationships of these enzymes.
In mammals, two di¡erent cytoplasmic isoenzymes of PLD
have been identi¢ed up to now (PLD1 and PLD2). In hu-
mans, two splice variants of the PLD1 isoenzyme (PLD1a
and PLD1b) were described by Hammond et al. [8,9]. The
other isoenzyme, PLD2, was only detected in mice [10] and
rats [11], but no occurrence of PLD2 in humans has been
published so far. Epidermal growth control is of particular
interest, because in many dermatoses a dysregulation of pro-
liferative and di¡erentiating processes was shown. As indi-
cated above, PLD is involved in the generation of mitotic
signals like diacylglycerol, therefore we focussed our interest
on the characterization of PLD in human keratinocytes.
Although PLD activity has been found in human keratino-
cytes [12^14], no data are available on the expression of the
di¡erent isoforms in these cells. In the present study, we iden-
ti¢ed the isoenzymes PLD1b and also PLD2 in the human
keratinocyte cell line HaCaT. Furthermore, peptide-speci¢c
antibodies were generated to identify PLD1 at the protein
level.
2. Materials and methods
2.1. Materials
1-Palmitoyl-2-[1-14C]palmitoylphosphatidylcholine (1.85^2.29 GBq/
mmol) was purchased from Amersham Buchler (Braunschweig, Ger-
many), [9,10-3H(N)]myristic acid (518 GBq/mmol) was purchased
from NEN DuPont (Bad Homburg, Germany), and cabbage PLD
was from Sigma (Muºnchen, Germany).
2.2. Cell culture
HaCaT cells [15] were grown in 90% Roswell Park Memorial In-
stitute medium (RPMI 1640), 10% heat-inactivated fetal calf serum
supplemented with penicillin (100 IU/ml) and streptomycin (100 Wg/
ml) in 80 cm2 tissue culture £asks (Nunc, Wiesbaden, Germany).
Media and culture reagents were obtained from Seromed-Biochrom
(Berlin, Germany).
2.3. Reverse transcriptase polymerase chain reaction (RT/PCR)
Total cellular RNA used to prepare cDNA was isolated using
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RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany). The reverse
transcription (RT) reaction was performed at 42‡C for 1 h in 20 Wl
of 50 mM KCl, 2.5 mM MgCl2, 20 mM Tris-HCl (pH 8.4), 2 mM
dNTPs (0.5 mM each), 200 ng of random hexamers (Life Technolo-
gies, Eggenstein, Germany) as primers, 10 mM DTT, 5 Wg of total
cellular RNA using 200 units SuperScript IIRT (Life Technologies,
Eggenstein, Germany). To terminate the reverse transcription samples
were incubated at 70‡C for 15 min. Remaining RNA was degraded by
an additional incubation at 37‡C for 20 min with 2 U of Escherichia
coli RNase H (Life Technologies, Eggenstein, Germany). The result-
ing cDNA was used directly for PCR or stored at 320‡C. Human
PLD1-speci¢c PCR primers (GGAGGGATTGACCTGGCCTA and
GCCACATCACGAGCCGCCTT) were designed using the Mac-
Molly Tetra program (Softgene GmbH, Berlin, Germany) and were
synthesized by TIB Molbiol (Berlin, Germany). PCR was carried out
in 50 Wl of 50 mM KCl, 1.5 mM MgCl2, 20 mM Tris-HCl (pH 8.4),
0.8 mM dNTPs (200 WM each), 4 WM primer (2 WM each) using 1.25
U of Taq DNA polymerase (Life Technologies, Eggenstein, Ger-
many). 1 WM of cDNA was added as PCR template. For control
reactions 1 Wl H2O and 1 Wl of 10 pg/Wl pBluescript containing the
hPLD1b gene, respectively, were used. Thirty-¢ve cycles of ampli¢ca-
tion were carried out as follows: at 92‡C for 1 min, at 55‡C for 1 min,
and at 72‡C for 1 min. 8 Wl of PCR products were analyzed by
electrophoresis in 2% agarose gels.
2.4. Preparation of peptide speci¢c antibodies
The peptide MSLKNEPRVNTS(C) corresponding to the amino-
terminal 12 amino acids of human PLD1, and the peptide
(C)TKEAIVPMEVWT corresponding to the carboxy-terminal 12
amino acids of human PLD1 were synthesized and puri¢ed using
procedures as described earlier [16]. In both peptides a cysteine in
the distal position was added as indicated above for coupling to a
carrier. This should not alter the antigenic properties of the peptides.
Antibodies against these peptides were then prepared by Eurogentec
(Seraing, Belgium) using a standard protocol [17]. A mixture of both
peptides was used for immunization in order to increase the proba-
bility of generating a PLD-speci¢c antiserum. Brie£y, the two syn-
thetic peptide fragments of PLD conjugated over the additional cys-
teine with keyhole limpet hemocyanin (1000 Wg each) were injected at
several sites into one rabbit, initially with complete Freund’s adjuvant,
followed by injection of peptide conjugates (500 Wg each) in complete
Freund’s adjuvant every 2 weeks. Ten days after the third booster
injection the blood of the animal was taken and sera were obtained
by centrifugation at 8000Ug for 20 min. 50 Wl aliquots of the sera
were stored at 320‡C. This polyclonal antiserum was termed
KNChPLD1 indicating that the antibodies were raised against the
N- and C-termini of human PLD1.
2.5. Sandwich ELISA
The sandwich ELISA technique was performed essentially as de-
scribed [16]. 100 Wl of antibody KNChPLD1 (1:500 in PBS containing
0.05% Tween 20, further designated PBST) was incubated in 96-well
ELISA plates for 1 h at 37‡C and ¢xed with 0.5% glutaraldehyde for
30 min at room temperature. After washing with PBST, the wells were
saturated with 200 Wl of a solution of 1% BSA in PBS for 1 h at 37‡C.
Following this blocking step, the wells were incubated with 0.1 Wg/ml
peptide mixture in PBST (peptide sequences are described in Section
2.4) overnight at 4‡C. After washing, the wells were incubated with
100 Wl of antibody KNChPLD1 (1:500 in PBST, or di¡erent dilutions
of antibodies were used as indicated) for 1 h at 37‡C. Detection of
peptide-bound antibodies were carried out by incubation with a per-
oxidase-conjugated swine anti-rabbit antibody (1:1000 in PBST) for
1 h at 37‡C. After thoroughly washing the wells 100 Wl substrate
solution (0.8 mg/ml phenylenediamine, 0.015% H2O2 in 0.1 M citrate
bu¡er, pH 6.0) was added. After 5 min at 37‡C the reaction was
stopped with 100 Wl 1.25 M sulfuric acid and the absorbance was
measured at 492 nm. Control experiments were performed without
speci¢c peptide, without antibody KNChPLD1 and with unspeci¢c
peptide (12 amino-terminal amino acids of human choline kinase,
the peptide was synthesized by Dr. Becker, Schering AG, Berlin,
Germany).
2.6. Preparation of cell homogenates
Cells were harvested using a cell scraper in 0.5^1 ml of 50 mM Na-
HEPES (pH 7.5), 3 mM EGTA, 80 mM KCl, 1 mM 1,4-dithiothrei-
tol, 3 mM MgCl2 and 2 mM CaCl2 (this bu¡er is further designated
assay bu¡er) containing additionally 1 mM PMSF and 10 WM leu-
peptin. After Dounce homogenization, the homogenate was centri-
fuged for 10 min at 400Ug to get rid of cell debris. The homogenate
was stored at 320‡C. For SDS-PAGE the homogenate was supple-
mented with detergents to obtain the following concentrations: 0.1%
(w/v) SDS, 1% (v/v) Triton X-100 and 0.5% (w/v) sodium deoxycho-
late prior to centrifugation. Protein was measured in samples diluted
1:20 in H2O by the BCA assay [18], with BSA as standard.
2.7. Immunoblotting
Cell homogenates, containing 1 and 10 Wg of protein, respectively,
were mixed with SDS sample bu¡er [19]. 0.1 M 1,4-dithiothreitol was
used instead of L-mercaptoethanol. Samples were separated by 7.5%
SDS-PAGE. After transfer to nitrocellulose membrane the blot was
incubated with 10% non-fat dry milk in PBS/0.1% Tween 20 overnight
at 4‡C to block non-speci¢c binding. The membrane was then incu-
bated with the KNChPLD1 antiserum 1:1000 in PBS/0.1% Tween 20/
0.5% BSA for 1 h at room temperature. Bound antibodies were de-
tected after washing using horseradish peroxidase-conjugated anti-
rabbit immunoglobulin antibodies (1:5000) and the ECL chemilumi-
nescent detection reagents according to the manufacturer’s instruc-
tions (Amersham Buchler, Braunschweig, Germany).
2.8. Measurement of phospholipase D activity in permeabilized cells
PLD activity was determined by measuring the transfer of phos-
pholipid phosphatidyl moieties, metabolically prelabeled with
[3H]myristic acid, in the presence of ethanol, into phosphatidylethanol
(phosphatidyltransferase activity) as described [20] with some modi¢-
cations. Cell lipids were radioisotopically labeled by incubation of 106
HaCaT cells (80% con£uence in 6-well plates) in culture medium
supplemented with 0.111 MBq of [9,10-3H(N)]myristic acid at 37‡C
for 24 h. Following the incubation, the cells were washed twice with
PBS. An equilibration at 37‡C for 5 h in keratinocyte basal medium
containing 10 mM HEPES, 0.56 g/l L-glutamine, 100 IU/ml penicillin,
100 Wg/ml streptomycin and 0.3 g/l fatty acid free BSA was per-
formed. After washing twice with PBS, cells were treated at 37‡C
for 30 min with 1 ml of prewarmed permeabilization bu¡er (perme-
abilization is necessary for penetration of ATPQS into the cell) con-
sisting of 120 mM potassium glutamate, 20 mM HEPES (pH 7.4), 20
mM potassium acetate, 3 mM magnesium chloride, 1 mM EGTA,
supplemented with 0.5 mM calcium chloride, 20 Wg/ml digitonin,
1 mg/ml BSA and 1% (v/v) ethanol, 500 WM MgATP and di¡erent
concentrations of GTPQS. The permeabilization is necessary to meas-
ure the in£uence of GTPQS. The enzymatic reaction was stopped by
the addition of 1.2 ml ice-cold 2% acetic acid in methanol. Cells were
harvested using a cell scraper and lipids were extracted as described
[21]. Organic phase was dried under a stream of nitrogen and lipids
were resuspended in 50 Wl of chloroform/methanol (1:1), and 15 Wl
were applied to high-performance thin-layer chromatography plates.
Separation was carried out in chloroform/methanol/30% aq.NH3.
(65:35:3, v/v). Radioactivity was quanti¢ed by radioscanning using
a Berthold LB 2821 HR thin-layer chromatography scanner (Bert-
hold, Wildbad, Germany). Phosphatidylethanol in the samples was
identi¢ed by comigration of an internal standard prepared with cab-
bage PLD.
2.9. Measurement of phospholipase D activity in cell homogenates
Phospholipid vesicles were used to assay cell homogenates for PLD
activity essentially as described [22]. Brie£y, vesicles were composed of
PE, PIP2 and DPPC in the molar ratio of 20:1:2. 18.5 kBq of 1-
palmitoyl-2-[1-14C]palmitoylphosphatidylcholine was added as radio-
active tracer (¢nal concentration of PC was 8.6 WM). The standard
assay was carried out in 30 Wl assay bu¡er (see also Section 2.6)
containing 5 Wl vesicle mix and 0.67 mg/ml of protein in cell homo-
genates and di¡erent concentrations of GTPQS. The incubation was
performed at 37‡C for 1 h. Lipids were extracted as described by Bligh
and Dyer [21] and separated by high-performance thin-layer chroma-
tography in chloroform/methanol/acetic acid (13:3:1, v/v). Radioac-
tivity was quanti¢ed by radioscanning using a Berthold LB 2821 HR
thin-layer chromatography scanner (Berthold, Wildbad, Germany).
Phosphatidylethanol in the sample was identi¢ed by comigration of
an internal standard prepared using cabbage PLD.
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3. Results and discussion
3.1. Preparation and characterization of a peptide-speci¢c
antibody against human phospholipase D1
Based on the human PLD1 cDNA sequence [8] we synthe-
sized peptides corresponding to residues 1^12 and 1063^1074
and peptide-speci¢c antibodies were produced in rabbit as an
important tool for further experiments. We used the sandwich
ELISA technique to determine the peptide speci¢city of this
new antibody. The extinction value obtained in the presence
of antibody KNChPLD1 together with the speci¢c peptide
mixture was set at 100% (Fig. 1, column 1). Control experi-
ments were carried out with antibody KNChPLD1 but with-
out peptide (column 2, peptide negative control), with anti-
body and with non-speci¢c control peptide (column 4),
without antibody and with peptide (column 3, antibody neg-
ative control). As shown in Fig. 1, the extinction values of the
control experiments reached at most 25%. Furthermore, the
extinction value using non-speci¢c control peptide was below
the negative controls represented by columns 2 and 3. In
another experiment we used di¡erent antibody KNChPLD1
concentrations and found that the dilution 1:500 is optimal
for this assay system (data not shown). From the results ob-
tained we concluded that the new peptide-speci¢c antibody
against amino- and carboxy-terminal peptides of human
PLD1 can be used for further studies.
3.2. Expression of phospholipase D in HaCaT cells
The expression of hPLD1 in the human keratinocyte cell
line HaCaT [15] was investigated in RT/PCR and Western
blot experiments. For ampli¢cation of the hPLD1 cDNA,
gene-speci¢c PCR primer pairs were used spanning the alter-
natively spliced exon of 114 bp [9] in order to discriminate
between hPLD1a (estimated product length: 571 bp) and
hPLD1b (estimated product length: 457 bp). Fig. 2 shows
the agarose gels in which RT/PCR products have been electro-
phoretically separated. cDNA used as template for the PCR
experiment shown in lane 1 was prepared using total RNA
isolated from HaCaT cells. Plasmid DNA containing the
hPLD1b cDNA was used for the control PCR experiment
(lane 2). The upper signals seen in both lanes correspond to
hPLD1 gene detection. hPLD1b cDNA was detectable in Ha-
CaT cells and in the control PCR as can be seen by the length
of the PCR product of 457 bp whereas hPLD1a cDNA was
not (no signal corresponding to a PCR product of 571 bp was
detectable). The second band of approximately 250 bp seen in
lane 1 was unexpected. Therefore, it was isolated from the
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Fig. 3. Western blot analysis of HaCaT cell homogenates. HaCaT
cell homogenates containing 10 Wg of protein (lanes 2 and 3) were
separated on 7.5% SDS-PAGE and subjected to Western blot analy-
sis as described in Section 2. Cell homogenate containing 1 Wg of
protein obtained from hPLD1b-overexpressing Sf9 cells was used as
positive control (lane 1). Positions of molecular weight standards
are indicated.
Fig. 2. Expression of phospholipase D isoforms in HaCaT cells as
assessed by RT/PCR. An ethidium bromide-stained 2% agarose gel
is shown after electrophoretic separation of RT/PCR products. In
lane 1 HaCaT cDNA was used as template whereas in lane 2
hPLD1b containing plasmid was used as template DNA. Control
experiment in the absence of template DNA is not shown, but no
PCR product was detectable. The experiment was repeated and sim-
ilar results were obtained.
Fig. 1. Characterization of the peptide speci¢ty of phospholipase D
antibody KNChPLD1 by sandwich ELISA. The sandwich ELISA
was carried out as described in Section 2.5. The signal represented
by column 1 was measured in the presence of antibody KNChPLD1
and PLD1 peptides and was set at 100%. Column 2: Signal ob-
tained in the presence of antibody KNChPLD1 but without peptide.
Column 3: Signal obtained in the absence of antibody KNChPLD1
but in the presence of peptide. Column 4: Signal obtained in the
presence of antibody KNChPLD1 and of the control peptide. Col-
umn 5: PBST control. The values represent the mean of two deter-
minations. The experiment was repeated twice and similar results
were obtained.
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agarose gel and sequenced using the cycle sequencing proce-
dure. Sequence comparison using the NIH nucleic acid data
base resulted in 98% identity to the gene for human PLD2
(data base entry by P.M. Steed, K.L. Clark, W.C. Boyar and
D.J. Lasala (1997), accession number AF033850). The ampli-
¢cation of hPLD2 cDNA using our hPLD1-speci¢c PCR pri-
mers was more random than expected because the selected
PCR primers are speci¢c for hPLD1 cDNA. An explanation
could be that both PLD genes show high homology and there-
fore it may be possible that the primers with high speci¢city
for hPLD1 cDNA also anneal with lower stringency to
hPLD2 cDNA. However, we conclude that in HaCaT cells
the mRNAs for hPLD1b and hPLD2 are present.
Despite the data at the mRNA level we studied human
PLD expression at the protein level as well and used the pep-
tide-speci¢c antibody (described in Section 3.1) for Western
blot analysis. Fig. 3 shows the Western blot corresponding to
SDS-PAGE in which cell homogenates were run and further
processed as described in Section 2.7. The signals obtained in
all three lanes in the upper part of the blot correspond to a
protein with an apparent molecular weight of about 110 kDa.
Furthermore, some distinct bands occurred in the lower part
of the blot corresponding to polypeptides of about 60 kDa.
The calculated molecular weights of hPLD1a and hPLD1b are
124 kDa and 117 kDa, respectively. Since the signal detected
in lane 1 corresponds to overexpression of hPLD1b in Sf9
cells we conclude that our peptide-speci¢c antibody is usable
for detection of hPLD1 in Western blot analysis. Thus, the
detected proteins with an apparent molecular weight of about
110 kDa seen in lanes 2 and 3 represent human phospholipase
D isolated from HaCaT cells, although the calculated and the
apparent molecular weights of hPLD1 are slightly di¡erent.
3.3. Regulation of phospholipase D by GTPQS
Mammalian PLD is known to be regulated by di¡erent
mechanisms. In HL-60 cells, it was demonstrated that cytosol
was required for the stimulatory e¡ect of GTPQS on PLD
activity indicating the involvement of small G-proteins [23].
Furthermore, Hammond et al. [8] showed that activation by
GTPQS is characteristic for the isoenzyme hPLD1. In order to
con¢rm that the 110 kDa protein is identical with human
cytosolic PLD we established the measurement of PLD activ-
ity in permeabilized cells and in vitro. Determination of PLD
activity was performed using the transphosphatidylation ac-
tivity of the enzyme generating the non-physiologic product
phosphatidylethanol when ethanol was present as a substrate.
Cell homogenates and permeabilized HaCaT cells, respec-
tively, were incubated with GTPQS. As shown in Fig. 4,
GTPQS caused a concentration-dependent increase of PLD
activity in cell culture experiments (Fig. 4A) as well as in vitro
(Fig. 4B) indicating the participation of small G-proteins in
PLD regulation in HaCaT cells. The concentrations of 15^100
Wmol/l for stimulation of PLD were in the same range as
reported for PLD in HL60 cells [24].
In conclusion, the present study revealed that the human
keratinocyte cell line HaCaT does express cytosolic PLD. At
the mRNA level we showed the expression of hPLD1b and,
for the ¢rst time in human cells, also the expression of
hPLD2. For investigating the expression of these enzymes at
the protein level peptide-speci¢c antibodies were used for de-
tection in Western blot experiments and PLD1 was detected in
HaCaT cells. Furthermore, involvement of small G-proteins
in the regulation of PLD activity in HaCaT cells was shown
using the guanine nucleotide analogue GTPQS which is char-
acteristic for the isoform hPLD1. Further studies are neces-
sary to elucidate the regulation and function of hPLD in
human keratinocytes in more detail.
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